No Result
View All Result
Success American Investors
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
Success American Investors
No Result
View All Result
Home Editor's Pick

The CFPB’s Overdraft and NSF Mess

by
April 2, 2024
in Editor's Pick
0
The CFPB’s Overdraft and NSF Mess
0
SHARES
5
VIEWS
Share on FacebookShare on Twitter

Nicholas Anthony

Between its proposal to restrict overdraft fees and nonsufficient fund (NSF) fees, the Consumer Financial Protection Bureau (CFPB) has created a mess.

When I testified before Congress, I warned that establishing price controls would likely lead to two outcomes: shortages of the restricted service and higher costs elsewhere. Still, the CFPB pressed ahead with its proposal to restrict overdraft fees to a soon‐​to‐​be‐​determined “benchmark fee.”

Yet that is not to say that the CFPB does not recognize the consequences I warned about. In fact, in a separate proposal to restrict NSF fees, the CFPB admits that restricting overdraft fees may lead financial institutions to raise fees elsewhere:

[If] the Overdraft Proposed Rule is finalized and reduces overdraft fee revenue for covered financial institutions, it may lead some institutions to consider imposing new fees. Increasing the prevalence of NSF fees on covered transactions could be one way that covered financial institutions respond, while market forces could lead even non‐​covered financial institutions to begin charging NSF fees on covered transactions.

Were it not for that, it seems unlikely that the regulator would have ever sought to restrict NSF fees given they are so uncommon. For example, the CFPB repeatedly stated that “many financial institutions in recent years have stopped charging NSF fees,” “NSF fees are rarely charged,” and the “CFPB understands that it is currently uncommon for financial institutions to charge NSF fees on covered transactions.” In other words, this proposal is a preemptive prohibition based on the expected, extended consequences of the CFPB’s other price controls.

Rather than begin a never‐​ending game of “regulatory whac‐​a‐​mole,” the CFPB (and the Biden administration) should drop its price controls.

Are you interested in learning more about price controls? Ryan Bourne’s latest book, The War on Prices, is available for pre‐​order here and will be released on May 14, 2024.

Previous Post

How to show real appreciation in the workplace

Next Post

Stossel TV Debunks Six Myths About Globalization

Next Post
Stossel TV Debunks Six Myths About Globalization

Stossel TV Debunks Six Myths About Globalization

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!
  • Trending
  • Comments
  • Latest
Vertica: The new Israeli start-up challenger to Viagra proving ‘life-changing’ for men with ED

Vertica: The new Israeli start-up challenger to Viagra proving ‘life-changing’ for men with ED

February 14, 2024
Idaho Bucks Managed Care Trend

Idaho Bucks Managed Care Trend

December 5, 2023

The Producer Price Index

September 9, 2023

CMKE Introduces PPM Subscription Model to Drive Cost Savings for Scottish Businesses

November 9, 2023

The Political Business Cycle 50 Years Later

0

0

0

0

The Political Business Cycle 50 Years Later

May 10, 2025

Why Elon Musk Is Right: The Case Against Subsidizing Amtrak

May 10, 2025

The Gold-Silver Ratio

May 10, 2025
Friday Feature: MCP Academy

Friday Feature: MCP Academy

May 9, 2025

Recent News

The Political Business Cycle 50 Years Later

May 10, 2025

Why Elon Musk Is Right: The Case Against Subsidizing Amtrak

May 10, 2025

The Gold-Silver Ratio

May 10, 2025
Friday Feature: MCP Academy

Friday Feature: MCP Academy

May 9, 2025

Disclaimer: SuccessAmericanInvestors.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

  • About us
  • Contact us
  • Privacy Policy
  • Terms & Conditions

Copyright © 2025 SuccessAmericanInvestors. All Rights Reserved.

No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock

Copyright © 2025 SuccessAmericanInvestors. All Rights Reserved.